VANBRUGH GROUP PRACTICE
LEVEL 2, GREENWICH CENTRE, 12 LAMBARDE SQUARE, LONDON
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 50 | 54 | 92.6% | |
| CKD 4 | 2008 | 209 | 251 | 83.3% | |
| CKD 5 | 2009 | 45 | 53 | 84.9% | |
| CKD 5 | 2010 | 32 | 38 | 84.2% | |
| CKD 5 | 2011 | 33 | 38 | 86.8% | |
| CKD 5 | 2012 | 36 | 43 | 83.7% | |
| CKD 5 | 2013 | 32 | 35 | 91.4% | |
| CKD003 | 2014 | 27 | 32 | 84.4% | |
| CKD003 | 2015 | 22 | 25 | 88.0% | |
| NM84 | 2016 | 21 | 36 | 58.3% | |
| NM84 | 2017 | 15 | 28 | 53.6% | |
| NM84 | 2018 | 11 | 25 | 44.0% | |
| NM84 | 2019 | 23 | 44 | 52.3% | |
| NM84 | 2020 | 15 | 37 | 40.5% | |
| NM84 | 2022 | 13 | 27 | 48.1% | |
| NM84 | 2023 | 16 | 33 | 48.5% |
